top of page
Якорь 5
Снимок экрана 2024-03-08 в 15.33.32.png
Fertility Global Challenge

The global challenge of fertility is a pressing issue in today's healthcare landscape, impacting individuals and societies around the world. Addressing this challenge requires a comprehensive approach that considers both medical and societal factors influencing reproductive health. At Deep Knowledge Group and Longevity Industry Analytics, we recognize the significance of fertility-related concerns and aim to contribute to the advancement of solutions. Our focus lies in collaborative efforts with leading experts and innovative clinics to develop and implement cutting-edge treatments that address fertility issues.

The complexity of this global health challenge demands a multifaceted strategy, incorporating advanced medical interventions, research, and public awareness initiatives. By leveraging our expertise and collaborating with stakeholders globally, we aspire to mitigate the impact of fertility challenges on individuals and enhance overall reproductive health. We welcome the engagement of investors, partners, and professionals who share our commitment to addressing fertility as a critical global health challenge. Together, we can foster advancements in reproductive medicine, promote awareness, and contribute to the well-being of individuals and communities affected by fertility issues worldwide

Global Perspective

The prevalence of fertility issueshas a profound impact on families, and communities globally, creating a significant public health challenge that extends beyond borders and cultural contexts. As our world faces an increasing prevalence of these health risks, it has become crucial to address the impact of birth rate issues that act as intermediate hosts for harmful bacteria or pose health risks themselves. The adverse effects of these bugs are widespread, impacting millions of people around the world. Understanding the factors influencing the prevalence of these harmful bugs is essential for effective prevention, diagnosis, and management. In the face of this growing challenge, it is imperative to unite efforts and resources to develop innovative solutions that can mitigate the consequences of these health threats and protect the well-being of communities worldwide.

The health risks posed by some harmful bugs like mosquitoes transferring malaria are well-known but the risks of many other harmful bugs are often neglected. This oversight is a growing global concern that demands attention. It's crucial to shift focus towards acknowledging and addressing the profound consequences of harmful bugs on a global scale. By raising awareness and fostering collaboration, we can work towards making the mitigation of these health threats a top global health priority for a healthier and safer world.

Percent of people affected by Fertility Issues

Fertility Global Challenge Ecosystem

Fertility, Autism, and Lyme Disease:

Exploring Connection 

Harmful bugs that carry Persistent Borrelia cysts, causing Lyme disease, may reawaken with aging, potentially influencing Alzheimer's progression. Recent research discovered Lyme Borrelia DNA in postmortem Alzheimer's brains, suggesting a potential link between these diseases. IHHT-MITOPRO provides a practical strategy to prevent latent Lyme Borreliosis, preserving immune system effectiveness.

Understanding these potential links between Lyme disease and Alzheimer's is crucial for comprehensive health management and emphasizes the importance of early intervention strategies. Let's delve deeper into the intricate interplay between these conditions.

Снимок экрана 2024-01-20 в 16.34.41.png

Fertility Global GeoDashboard

100 000

Clinic Trials 


Top Clinics

200 000


500 000 

Data Points 

Якорь 3

Read More

Fertility Related Expenditures Market

Anticipated to undergo significant expansion, the global market for Alzheimer's Disease methods of treatment is poised to grow from USD 2.2 billion in 2021 to USD 13.7 billion in 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of around 4.4%.

The upsurge in healthcare advancements, backed by substantial investments from major corporations and government institutions, underscores the increasing importance of precise diagnostics and refined treatment approaches in addressing the intricacies of Alzheimer's disease. This extends to providing comprehensive support for individuals across the entire spectrum, including those with mild forms.

Fertility Issues Diagnostics Market Size, $bn

Experiencing a Compound Annual Growth Rate (CAGR) of approximately 8% during this period, the market for Alzheimer's disease diagnostic tools is on a robust trajectory. This growth is propelled by heightened awareness and reporting of Alzheimer's cases, advancements in diagnostic technologies, and sustained investments in research and development aimed at creating more precise and effective diagnostic tools.


Projections indicate a steady market expansion, with an anticipated rise from USD 3.3 billion in 2022 to USD 7.1 billion in 2030. This underscores the increasing demand for advanced diagnostic solutions in detecting Alzheimer's, with a focus on early identification and enhanced condition management.

Fertility Global Challenge
Ecosystem Dashboard

The Bad Bugs Challenge Ecosystem Dashboard is a centralized hub designed to meet all the market and business intelligence needs of its users. It offers comprehensive support, encompassing benchmarking for companies, technologies, and thorough competitive and SWOT analysis for over 12000 clinics, 3300+ clinical trials, 3000+ investors, and 25,000+ data inputs within the Bad Bugs sector.

Снимок экрана 2023-12-09 в 14.27.38.png
Screenshot Alzheimers 2.png

Fertility Challenge
Patient Logistic Pathway

Explore the comprehensive journey of Alzheimer's patients through the interactive Logistic Pathway. Each stage offers a concise overview, and by selecting individual stages, you can delve into detailed descriptions that provide insights into AI-driven diagnostic, treatment, and management processes tailored specifically to ASD. For more in-depth information about clinics, diagnostics, and treatments, use the Global Autism Dashboard.

Якорь 4


Alzheimers Teaser Preview.png
Coming Soon

One Pager

Alzheimers One-pager Preview.png
Coming Soon


Alzheimers Report Preview.png
Coming Soon

Malaria Clinical Trials

The United States stands as the primary research center for ASD clinical trials, hosting over 53% of these studies.


More than 5% of clinical trials are launched in France. Canada, Taiwan, UK and China have similar number of clinical trials, each around 3%. Together, European countries make more than 18% of clinical trials. In total, more than 50 countries have participated in Autism Spectrum Disorder clinical trials.

After 2017, the annual number of clinical trials more than doubled increasing to 134 studies per year. The jump in clinical trials after 2017 signals a rising awareness of ASD significance.

The most significant players in the market are Massachusetts General Hospital (USA), Stanford University (USA), National Taiwan University Hospital (Taiwan), Yale University (USA), University of California, Los Angeles (USA),  Children's Hospital Medical Center, Cincinnati (USA), National Institute of Mental Health (USA).

Strategic Partner Projects


Lyme Disease

Global Pandemia


Autism Global

Challenge Ecosystem